A phase ii trial of bevacizumab in patients with recurrent solid tumor brain metastases who have progressed following whole brain radiation therapy (WBRT): Final results

Authors
Category Primary study
JournalNeuro-Oncology
Year 2019
This article has no abstract
Epistemonikos ID: 36df4ffe9003950d7eb89cb907f4cd14348d1c6b
First added on: Feb 11, 2025